Neuroendocrine tumours trials in Poland
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2/3RecruitingTrial-stage medicine
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Gliwice, Katowice, Krakow, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755EU 2025-521043-20-00Registry updated 2026-10-30
No phaseRecruitingResearch participation
Multicenter Study for External Validation of the TB-NET Score
- Where
- Krakow
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532Registry updated 2026-10-29
Phase 3RecruitingTrial-stage medicine
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
- Where
- Gdansk, Katowice, Wroclaw
- Age
- 18 years and over
- People
- 390 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07544654EU 2025-523869-22-00Registry updated 2026-10-28
Phase 1/2Not yet recruitingTrial-stage medicine
DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Wroclaw
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07707895EU 2026-525634-27-00Registry updated 2026-10-27
Phase 3RecruitingResearch participation
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Bydgoszcz, Warsaw
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00EU 2025-524160-38-00Registry updated 2026-10-01
Phase 3RecruitingTrial-stage medicine
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Cracow, Gdansk, Gliwice, Poznan, Warsaw, Warszawa
- Age
- 12 years to 100 years
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752EU 2024-518325-15-00Registry updated 2026-09-11
Phase 3Not yet recruitingResearch participation
Tandem therapy LutaPol/ltraPol ( I 77Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasmas.
- Where
- Cracow, Kielce, Warsaw
- Age
- 18 years and over
- People
- 92
- Run by
- Narodowe Centrum Badan Jadrowych
See details and how to join2024-516503-17-01EU 2024-516503-17-01Registry updated 2026-08-19
Phase 3RecruitingResearch participation
Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)
- Where
- Gdansk, Warsaw, Wilkowice
- Age
- 18 years and over
- People
- 156 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-520050-38-00EU 2024-520050-38-00Registry updated 2026-08-12
Phase 2RecruitingTrial-stage medicine
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Lublin, Poznan
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058EU 2023-504247-13-00Registry updated 2026-07-23
No phaseNot yet recruitingResearch participation
CardioNETPOL National Registry of Carcinoid Heart Disease
- Where
- Warsaw
- Age
- 18 years and over
- People
- 120
- Run by
- National Institute of Cardiology, Warsaw, Poland
See details and how to joinNCT07450287Registry updated 2026-03-04
No phaseNot yet recruitingResearch participation
Advanced Endoscopic Resections for Rectal Neoplasms
- Where
- Krakow
- Age
- 18 years and over
- People
- 300
- Run by
- Jagiellonian University
See details and how to joinNCT07410767Registry updated 2026-02-18
No phaseRecruitingResearch participation
Clinical Application of the J-PET Scanner Prototype
- Where
- Krakow
- Age
- 18 years and over
- People
- 25
- Run by
- Jagiellonian University
See details and how to joinNCT06242119Registry updated 2025-02-19
All Neuroendocrine tumours trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.